Molecular MedicineTranslational control of cell cycle and differentiation
ICREA Research Professor
Recent years have seen a paradigm shift in our understanding of gene activity and regulation. It is now clear that processing of primary transcripts as well as translational control open a myriad of opportunities for gene regulation, which are extensively used in virtually every human gene. However, how these events are regulated and how alterations of these finely tuned processes contribute to physio/pathological processes is not yet well understood.
The primary interest of our group has been to understand the molecular mechanisms that dictate alternative 3’ UTR formation and the temporal and spatial translational control of specific mRNAs during cell cycle progression and chromosome segregation, senescence and related pathologies. Cell cycle progression is programmed, at least in part, by stored silent mRNAs. These mRNAs are not translated en masse at any one time, or even at any one place; rather, their translation is specifically regulated by sequences located at their 3´-untranslated regions (3´-UTRs) and their binding proteins.
Our work focuses on four main lines of research:
First, to elucidate the mechanisms underlying the translational control by cytoplasmic polyadenylation cis-acting elements and trans-acting factors:
1) Genome-wide identification of the mRNAs that are regulated by nuclear and cytoplasmic changes in their poly(A) tail length;
2) Determination of the configuration of cis-acting elements that define the temporal and spatial translational regulation;
3) Functional and structural characterization of the ribonucleoprotein (RNPs) complexes that mediate this translational regulation.
Second, to obtain insights in how this translational control circuit regulates cell cycle progression by establishing a molecular circuit, stabilized by positive and negative feed-back loops to generate an irreversible self sustain hysteric system with molecular memory and switch-like phase transitions.
Third, to explore the role of these mRNA processing and translation mechanisms in the reprogramming of gene expression in tumoral events and angiogenesis and the development of tools with prognostic and therapeutic value.
Forth, to study the symmetric distribution of cellular components (research directed by Oriol Gallego, see www.gallegolab.org)
1)A comparative analysis of Multisubunit Tethering Complexes
2)Characterize the interplay between the transport of vesicles and mRNA localization
- AICR (Association for International Cancer Research)
- ICREA (Catalan Institute of Research and Advanced Studies)
- Ministerio de Ciencia e Innovación (Spanish Ministry of Science and Innovation)
- AGAUR (Agència de Gestió d’Ajuts Universitaris i de Recerca)
Group news & mentions
Reportaje sobre las principales estrategias que están desarrollando científicos españoles de primera línia mundial para encontrar nuevas fórmulas terapéuticas contra el cáncer.
El concurso "La Vanguardia de la ciencia" organizado por el periódico La Vanguardia y la Fundación Catalunya - La Pedrera ha elegido una investigación de
Upcoming Programme Events
Upcoming Programme Events
The course will be divided into two groups, each with 15 participants. Each group will attend two 4-h sessions, held over two consecutive weeks as follows:
- Group 1: Tuesday 21 and 28 April. 10:00 to 14:00
- Group 2: Thursday 23 and 30 April. 10:00 to 14:00
You should download the trial version of Indesign onto your pc and bring it with you to the course.
Speaker: Prof. Boris Turk, PhD
Head of Dept. Biochem. & Mol. & Struct. Biol.
Speaker: César González, IBMB-CSIC
Speaker: Fátima Bosch, PhD
Center of Animal Biotechnology and Gene Therapy.
Universitat Autònoma de Barcelona, Bellaterra - Spain